Holen Sie sich die Stockscreener-App
1.36
1.45%
-0.02
Handel nachbörslich:
1.40
0.04
+2.94%
Schlusskurs vom Vortag:
$1.38
Offen:
$1.36
24-Stunden-Volumen:
487.74K
Relative Volume:
0.59
Marktkapitalisierung:
$144.99M
Einnahmen:
$45.44M
Nettoeinkommen (Verlust:
$-35.43M
KGV:
-4.00
EPS:
-0.34
Netto-Cashflow:
$-25.39M
1W Leistung:
-2.16%
1M Leistung:
-34.62%
6M Leistung:
-60.35%
1J Leistung:
-65.13%
1-Tages-Spanne:
$1.335
$1.38
1-Wochen-Bereich:
$1.32
$1.42
52-Wochen-Spanne:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Firmenname
Maxcyte Inc
Sektor
Branche
Telefon
301-517-5556
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Vergleichen Sie MXCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.36 | 142.85M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | Eingeleitet | Stephens | Overweight |
| 2023-11-29 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | BTIG Research | Buy |
| 2021-08-24 | Eingeleitet | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | Stephens | Overweight |
| 2021-08-24 | Eingeleitet | Stifel | Buy |
| 2021-08-24 | Eingeleitet | Wedbush | Outperform |
| 2021-08-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
Should value investors consider MaxCyte Inc.Weekly Volume Report & Reliable Entry Point Trade Alerts - khodrobank.com
Will MaxCyte Inc. price bounce be sustainableJuly 2025 Update & Technical Buy Zone Confirmation - Newser
Historical volatility pattern of MaxCyte Inc. visualizedOil Prices & Free Technical Confirmation Trade Alerts - Newser
Applying Elliott Wave Theory to MaxCyte Inc.Market Performance Report & AI Powered Buy and Sell Recommendations - Newser
Using economic indicators to assess MaxCyte Inc. potential2025 Stock Rankings & Real-Time Chart Pattern Alerts - Newser
Measuring MaxCyte Inc.’s beta against major indicesMarket Trend Review & Growth Focused Stock Reports - Newser
How to integrate MaxCyte Inc. into portfolio analysis toolsEarnings Trend Report & Growth Focused Stock Reports - Newser
How hedge fund analytics apply to MaxCyte Inc. stockPortfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
How to use Fibonacci retracement on MaxCyte Inc.Stock Surge & Safe Swing Trade Setup Alerts - Newser
What’s the recovery path for long term holders of MaxCyte Inc.Earnings Trend Report & Verified Entry Point Signals - Newser
Momentum divergence signals in MaxCyte Inc. chartCEO Change & Reliable Price Action Trade Plans - Newser
Is it too late to sell MaxCyte Inc.2025 Historical Comparison & AI Based Buy and Sell Signals - Newser
Can MaxCyte Inc. continue delivering strong returnsTrade Analysis Report & Free Fast Gain Swing Trade Alerts - khodrobank.com
Is MaxCyte Inc. attractive for institutional investors2025 Market Overview & Smart Swing Trading Alerts - khodrobank.com
Multi asset correlation models including MaxCyte Inc.July 2025 Highlights & Daily Stock Trend Watchlist - Newser
Is MaxCyte Inc. on track to beat earningsEarnings Recap Summary & Weekly Sector Rotation Insights - khodrobank.com
Technical signs of recovery in MaxCyte Inc.July 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
Relative strength of MaxCyte Inc. in sector analysis2025 Major Catalysts & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-09-02 00:49:26 - Newser
How does MaxCyte Inc. score in quality rankingsWeekly Earnings Recap & Reliable Price Breakout Alerts - khodrobank.com
Analyzing recovery setups for MaxCyte Inc. investors2025 Winners & Losers & Detailed Earnings Play Strategies - Newser
Is MaxCyte Inc. a top pick in the sector2025 Support & Resistance & AI Powered Market Trend Analysis - خودرو بانک
What is the PEG ratio of MaxCyte Inc.July 2025 Setups & Growth Oriented Trading Recommendations - khodrobank.com
MaxCyte Inc. stock chart pattern explainedWeekly Profit Recap & Verified Technical Trade Signals - Newser
How to recover losses in MaxCyte Inc. stockTrade Entry Summary & Precise Buy Zone Identification - Newser
Fibonacci Support Holding Strong in MaxCyte Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Can MaxCyte Inc. hit a new high this month2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Signal strength of MaxCyte Inc. stock in tech scannersQuarterly Profit Report & Daily Profit Focused Screening - Newser
Visual analytics tools that track MaxCyte Inc. performance2025 Key Highlights & Detailed Earnings Play Strategies - Newser
What to expect from MaxCyte Inc. in the next 30 days2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Has MaxCyte Inc. found a price floorJuly 2025 Action & AI Enhanced Trading Signals - Newser
How to build a dashboard for MaxCyte Inc. stockEarnings Trend Report & Technical Buy Zone Confirmation - Newser
Can technical indicators confirm MaxCyte Inc.’s reversalEntry Point & AI Driven Stock Reports - Newser
Finanzdaten der Maxcyte Inc-Aktie (MXCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Maxcyte Inc-Aktie (MXCT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
161,811 |
| Masoud Maher | President and CEO |
Aug 13 '25 |
Buy |
1.37 |
75,000 |
102,915 |
175,000 |
| Erck Stanley C | Director |
Aug 13 '25 |
Buy |
1.37 |
100,000 |
137,220 |
398,328 |
| DOUGLAS RICHARD | Director |
Aug 13 '25 |
Buy |
1.39 |
80,000 |
111,040 |
230,577 |
| Brooke William W | Director |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
150,879 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):